Abstract
Leukotrienes (LTs) are a group of biologically highly potent mediators of inflammation, synthesised in the first metabolic step by 5-lipoxygenase from 20 carbon fatty acids, predominantly arachidonic acid. They include the cysteinyl leukotrienes LTC4, LTD4, LTE4, which cause bronchoconstriction, chemotaxis and enhanced blood vessel-permeability, and therefore play a major role in asthma, and the dihydroxyeicosatetraenoate LTB4, an important mediator for acute and chronic inflammatory ailments. Inhibition of leukotriene biosynthesis therefore is a promising target for combating a number of diseases. Plant secondary metabolites offer a structurally very diverse potential source of new therapeutic leads. The aim of this review is to update the current knowledge of plant compounds with inhibitory effects on leukotriene metabolism, by presenting results published in the last seven years. Substances are presented with their IC50 values together with the activities of the positive controls to enable better comparability. Inhibitory effects of extracts are not discussed.
Keywords: Kniphofia foliosa, Clerodane Type Diterpenes, FLAP inhibitors, Atractylodes lancea, Polyprenylated Hydroquinones, Maesanin
Current Organic Chemistry
Title: Inhibition of Leukotriene Biosynthesis by Secondary Plant Metabolites
Volume: 12 Issue: 8
Author(s): Michael Adams and Rudolf Bauer
Affiliation:
Keywords: Kniphofia foliosa, Clerodane Type Diterpenes, FLAP inhibitors, Atractylodes lancea, Polyprenylated Hydroquinones, Maesanin
Abstract: Leukotrienes (LTs) are a group of biologically highly potent mediators of inflammation, synthesised in the first metabolic step by 5-lipoxygenase from 20 carbon fatty acids, predominantly arachidonic acid. They include the cysteinyl leukotrienes LTC4, LTD4, LTE4, which cause bronchoconstriction, chemotaxis and enhanced blood vessel-permeability, and therefore play a major role in asthma, and the dihydroxyeicosatetraenoate LTB4, an important mediator for acute and chronic inflammatory ailments. Inhibition of leukotriene biosynthesis therefore is a promising target for combating a number of diseases. Plant secondary metabolites offer a structurally very diverse potential source of new therapeutic leads. The aim of this review is to update the current knowledge of plant compounds with inhibitory effects on leukotriene metabolism, by presenting results published in the last seven years. Substances are presented with their IC50 values together with the activities of the positive controls to enable better comparability. Inhibitory effects of extracts are not discussed.
Export Options
About this article
Cite this article as:
Adams Michael and Bauer Rudolf, Inhibition of Leukotriene Biosynthesis by Secondary Plant Metabolites, Current Organic Chemistry 2008; 12 (8) . https://dx.doi.org/10.2174/138527208784577349
DOI https://dx.doi.org/10.2174/138527208784577349 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Chemistry and Biology of Carbohydrates
Carbohydrates are one of the most abundant natural products and are considered to be extremely important biomolecules for their ever-increasing impact on chemistry and biology. Their role in several important biological processes, notably energy storage, transport, modulation of protein function, intercellular adhesion, malignant transformation, signal transduction, viral, and bacterial cell ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke
Current Drug Targets Novel Metal Nanoparticles Stabilized with (2R,4R)-2,4-bis(diphenylphosphino) Pentane on SiO2. Their Use as Catalysts in Enantioselective Hydrogenation Reactions
Current Organic Chemistry Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs
Inflammation & Allergy - Drug Targets (Discontinued) Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators
Current Topics in Medicinal Chemistry Substrate Specificity of Rat DESC4, a Type II Transmembrane Serine Protease
Protein & Peptide Letters Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways
Anti-Cancer Agents in Medicinal Chemistry Genomics of Chronic Obstructive Pulmonary Disease (COPD); Exploring the SNPs of Protease-Antiprotease Pathway
Current Genomics Curcumin - Properties, Applications and Modification of Structure
Mini-Reviews in Organic Chemistry Psychosocial Stress, Emotions and Cytokine-Related Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological Modulation of Th17
Recent Patents on Inflammation & Allergy Drug Discovery Editorial [Hot Topic:Toward Translational Research on VIP AND PACAP (Executive Editor: A. Arimura)]
Current Pharmaceutical Design Cardiovascular effect of Nigella sativa L. Aqueous Extract in Normal Rats
Cardiovascular & Hematological Disorders-Drug Targets Use of Antihistamines in Ocular Therapy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Role of Selectins During Lung Inflammation and Their Potential Impact for Innovative Therapeutic Strategies
Current Respiratory Medicine Reviews Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology Structure-Activity Relationships of Flavonoids
Current Organic Chemistry Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology Endovascular Treatment of Pulmonary and Cerebral Arteriovenous Malformations in Patients Affected by Hereditary Haemorrhagic Teleangiectasia
Current Pharmaceutical Design Therapeutic Monoclonal Antibodies: Strategies and Challenges for Biosimilars Development
Current Medicinal Chemistry